Wednesday, March 18, 2026 | 11:05 PM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch
Sanket Koul

Sanket Koul

Sanket Koul

Sanket Koul is a mass communication graduate with a PG diploma in English Journalism from IIMC Delhi. As a correspondent at Business Standard, he covers the pulse of the social sector, from industry and institutional developments, to the government's latest moves in education, healthcare, pharmaceuticals and medical devices sectors.

Sanket Koul is a mass communication graduate with a PG diploma in English Journalism from IIMC Delhi. As a correspondent at Business Standard, he covers the pulse of the social sector, from industry and institutional developments, to the government's latest moves in education, healthcare, pharmaceuticals and medical devices sectors.

Email

Page 37 - Sanket Koul

PM Modi announces 75,000 new medical seats in next 5 years in I-Day speech

Need to develop education system, ensure youth no longer forced to study abroad, says PM Modi

PM Modi announces 75,000 new medical seats in next 5 years in I-Day speech
Updated On : 15 Aug 2024 | 8:11 PM IST

OPD services hit across hospitals as doctors continue strike for 3rd day

A drop of 20% and 40% was reported in laboratory tests and radiological interventions like X-rays and CT scans, respectively

OPD services hit across hospitals as doctors continue strike for 3rd day
Updated On : 14 Aug 2024 | 9:40 PM IST

Yatharth Hospitals Q1FY25 result: Net profit up 60%, revenue rises 37%

The company reported 9 per cent on-year increase in its average revenue per occupied bed (Arpob) at Rs 30,551 in Q1FY25, with bed occupancy rising to 61 per cent in Q1 from 51 per cent last year

Yatharth Hospitals Q1FY25 result: Net profit up 60%, revenue rises 37%
Updated On : 14 Aug 2024 | 1:33 PM IST

CBI takes over investigation into Kolkata doctor's rape-murder case

Officials from Delhi along with forensic scientists to reach Bengal's capital today

CBI takes over investigation into Kolkata doctor's rape-murder case
Updated On : 13 Aug 2024 | 10:41 PM IST

Ipca Labs Q1 results: Net profit rises 18% to Rs 192 cr, revenue up 32%

The firm's revenue from operations rose to Rs 2,093 crore, a 32 per cent rise from Rs 1,585 crore reported in Q1FY24

Ipca Labs Q1 results: Net profit rises 18% to Rs 192 cr, revenue up 32%
Updated On : 13 Aug 2024 | 7:18 PM IST

Nationwide doctor strike against Kolkata rape-murder hits services

Protests by doctors demanding justice and better workplace security began in Kolkata and eventually spread to other parts of the country

Nationwide doctor strike against Kolkata rape-murder hits services
Updated On : 12 Aug 2024 | 10:25 PM IST

Patient influx, test volumes raise Metropolis Healthcare's profit by 31%

Commenting on the results, Ameera Shah, Executive Chairperson and Whole-time Director, Metropolis Healthcare, said that the company has consistently achieved high growth in patient volume

Patient influx, test volumes raise Metropolis Healthcare's profit by 31%
Updated On : 11 Aug 2024 | 1:21 PM IST

Clinical trial waiver only if drugs have greater benefits, says govt

A senior official in the health ministry said that the rule will help to make available essential drugs that have a significant therapeutic advance over the current standard care

Clinical trial waiver only if drugs have greater benefits, says govt
Updated On : 08 Aug 2024 | 10:39 PM IST

Separate marketing code: Medical devices industry welcomes govt's move

A separate marketing practices code has been a long-standing demand for medical devices. Currently, the industry has to comply with the marketing practices code for pharmaceuticals

Separate marketing code: Medical devices industry welcomes govt's move
Updated On : 07 Aug 2024 | 10:02 PM IST

Dr Lal PathLabs Q1 results: Net profit up by 29.1%, revenue rises by 11.3%

The company's revenue from operations rose to Rs 602 crore in Q1FY25, an 11.3 per cent Y-o-Y growth from Rs 541 crore reported in Q1FY24

Dr Lal PathLabs Q1 results: Net profit up by 29.1%, revenue rises by 11.3%
Updated On : 07 Aug 2024 | 9:16 PM IST

Indian pharma market registers over 6% growth in July '24: Pharmarack

"Seasonality-driven molecules and molecular combinations, especially anti-infectives, have shown a relatively stronger volume-driven growth," the firm stated in its report

Indian pharma market registers over 6% growth in July '24: Pharmarack
Updated On : 07 Aug 2024 | 7:13 PM IST

India's tryst with heart-breaking fourth-place finishes at the Olympics

With just four days for the closing ceremony of the Paris Games, India stares at the possibility of returning home with few medals

India's tryst with heart-breaking fourth-place finishes at the Olympics
Updated On : 07 Aug 2024 | 3:13 PM IST

Fortis Healthcare Q1 results: Profit rises 40% over hospital biz growth

The company's revenue from operations rose to Rs 1,859 crore in Q1FY25, a 12.2 per cent Y-o-Y rise from Rs 1,657 crore reported in Q1FY24

Fortis Healthcare Q1 results: Profit rises 40% over hospital biz growth
Updated On : 06 Aug 2024 | 9:56 PM IST

Gland Pharma Q1 FY25 results: Net profit falls 26%, revenue rises 16%

The decrease in the group's consolidated Ebitda margin is being attributed to the negative Ebitda reported by Cenexi, its recent acquisition

Gland Pharma Q1 FY25 results: Net profit falls 26%, revenue rises 16%
Updated On : 06 Aug 2024 | 7:14 PM IST

Kerala, Tamil Nadu see fewer hospital admissions under Ayushman Bharat

The lesser numbers in Telangana are due to the presence of the state's own health insurance scheme for the poor, 'Aarogyasri,' which later merged with AB-PMJAY only in 2021

Kerala, Tamil Nadu see fewer hospital admissions under Ayushman Bharat
Updated On : 05 Aug 2024 | 5:45 PM IST

SC says no major breach in NEET-UG, raises concerns over NTA's exam conduct

Asks Centre's high-level committee to review NTA's ops and recommend reforms

SC says no major breach in NEET-UG, raises concerns over NTA's exam conduct
Updated On : 02 Aug 2024 | 9:35 PM IST

Govt agencies conducting risk-based inspections of pharma units: Nadda

Over 400 drug manufacturing units, including MSMEs, inspected after high frequency of NQS reports

Govt agencies conducting risk-based inspections of pharma units: Nadda
Updated On : 02 Aug 2024 | 9:33 PM IST

GSK Pharma Q1 FY25 results: Net profit rises 37%, revenue up 6.9%

GSK Pharma's stocks were up by 2.49 per cent, ending the day's trade at Rs 2,824.45 apiece on the Bombay Stock Exchange (BSE)

GSK Pharma Q1 FY25 results: Net profit rises 37%, revenue up 6.9%
Updated On : 02 Aug 2024 | 8:42 PM IST

Sun Pharma Q1 results: Profit zooms 40% on robust global specialty sales

On a sequential basis, the company exhibited a 6.8 per cent rise in net profit, while its revenue grew by 5.5 per cent, from Rs 2,655 crore and Rs 12,380.7 crore reported in Q3 FY24, respectively

Sun Pharma Q1 results: Profit zooms 40% on robust global specialty sales
Updated On : 01 Aug 2024 | 11:31 PM IST

Max Healthcare Q1 results: Net profit drops 1.6%, revenue up by 20%

Max to invest Rs 230 crore to set up 250 bed hospital in Mohali

Max Healthcare Q1 results: Net profit drops 1.6%, revenue up by 20%
Updated On : 01 Aug 2024 | 8:40 PM IST